September is Ovarian Cancer Awareness month - help raise awareness of the risks, signs, and symptoms of disease by wearing TEAL!
Ovarian cancer is the leading cause of death among gynecological cancers each year. In 2015, approximately 21,290 women will be diagnosed with ovarian cancer in the United States, and an estimated 14,180 will die from the disease. About 5% of cancer deaths among women are attributed to ovarian cancer.
The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) supports high-impact, cutting-edge research that fills unmet needs. The OCRP establishes priorities to target the most critical needs along the pipeline from basic to translational to clinical research and to push the field of ovarian cancer forward in our vision to eliminate this disease. Our current research priorities include:
- Understanding the precursor lesion/stem cell, microenvironment, and pathogenesis/progression of all types of ovarian cancer including rare subtypes
- Developing or improving performance and reliability of screening, diagnostic approaches, and treatment
- Developing and validating models to study initiation and progression of ovarian cancer
- Addressing issues in primary prevention and survivorship
- Investigating tumor response to therapy including tumor survival, dormancy, cell death, clonal evolution, and tumor heterogeneity
- Enhancing pool of ovarian cancer scientists
Ovarian Cancer Research Funding Directory
- $236.45 million FY97-FY14
- $20.0 million FY15